Evotec
Ouafa Zaki is a seasoned professional in the field of biotechnologies with extensive experience in antibody production and purification. Currently serving as a Senior Research Assistant at Evotec since March 2019, Ouafa previously worked as an Assistant Ingénieur at INSTITUT CLAUDIUS REGAUD, where responsibilities included managing monoclonal antibody production projects from inception to purification. Prior to this, Ouafa served as an Engineer at INSERM, focusing on similar projects, and at Millegen as both an Engineer and a Senior Technician, where contributions included the construction of human antibody fragment libraries and recombinant antibody selection using phage display technology. Educational credentials include a DESU in Biotechnologies and a Maîtrise in Biotechnologies from Université Paul Sabatier.
This person is not in any teams
This person is not in any offices
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.